Zobrazeno 1 - 10
of 2 944
pro vyhledávání: '"E, Vokes"'
Autor:
James M. Dolezal, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody, Aaron S. Mansfield, Sagar Rakshit, Radhika Bansal, Melanie C. Bois, Aaron O. Bungum, Jefree J. Schulte, Everett E. Vokes, Marina Chiara Garassino, Aliya N. Husain, Alexander T. Pearson
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Safe clinical deployment of deep learning models for digital pathology requires reliable estimates of predictive uncertainty. Here the authors describe an algorithm for quantifying whole-slide image uncertainty, demonstrating their approach with mode
Externí odkaz:
https://doaj.org/article/3782f0100a0e42dd916744ca0dcd64bc
Autor:
Ari J. Rosenberg, Evgeny Izumchenko, Alexander Pearson, Zhen Gooi, Elizabeth Blair, Theodore Karrison, Aditya Juloori, Daniel Ginat, Nicole Cipriani, Mark Lingen, Hillary Sloane, Daniel L. Edelstein, Kirsten Keyser, Johannes Fredebohm, Frank Holtrup, Frederick S. Jones, Daniel Haraf, Nishant Agrawal, Everett E. Vokes
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) has a favorable prognosis which has led to efforts to de-intensify treatment. Response-adaptive de-escalated treatment is promising, however improved biomarkers are
Externí odkaz:
https://doaj.org/article/9a900a0e9acd46aa9f1e55c493688248
Autor:
Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr, Sherin J. Rouhani, Carolina Soto Chervin, George Steinhardt, Angela M. Lager, Pankhuri Wanjari, Renuka Malik, Philip P. Connell, Steven J. Chmura, Aditya Juloori, Philip C. Hoffman, Mark K. Ferguson, Jessica S. Donington, Jyoti D. Patel, Everett E. Vokes, Ralph R. Weichselbaum, Christine M. Bestvina, Jeremy P. Segal, Sean P. Pitroda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Immune checkpoint blockade (ICB) improves outcomes in non-small cell lung cancer (NSCLC) though most patients progress. There are limited data regarding molecular predictors of progression. In particular, there is controversy regarding the r
Externí odkaz:
https://doaj.org/article/82195ffa5c7b45b097938796d4698839
Autor:
Smith, B. T. D.
Publikováno v:
The Journal of Theological Studies, 1939 Jul 01. 40(159), 287-288.
Externí odkaz:
https://www.jstor.org/stable/23953422
Autor:
Reynders, D. B.
Publikováno v:
Recherches de théologie ancienne et médiévale, 1939 Jul 01. 11, 295-295.
Externí odkaz:
https://www.jstor.org/stable/26184284
Autor:
Mathew, Gervase
Publikováno v:
Blackfriars, 1939 Jun 01. 20(231), 462-464.
Externí odkaz:
https://www.jstor.org/stable/43811480
Autor:
Thomas A. Hensing, MD, MS, Xiaofei Wang, PhD, Thomas E. Stinchcombe, MD, Junheng Gao, MS, Michael V. Knopp, MD, PhD, Mark Watson, MD, PhD, Arkadiusz Z. Dudek, MD, PhD, Stephen L. Graziano, MD, Jyoti D. Patel, MD, Bryan A. Faller, MD, Konstantin H. Dragnev, MD, David Kozono, MD, PhD, Everett E. Vokes, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100208- (2021)
Introduction: The sequence of chemotherapy and pembrolizumab may affect antitumor immune response and efficacy of immunotherapy. Methods: This multicenter, randomized, phase 2 trial was designed to evaluate the efficacy of two sequences of chemothera
Externí odkaz:
https://doaj.org/article/df3a2223967b484e8c1430c2888b54cb
Autor:
Misha C. Tran, Garth W. Strohbehn, Theodore G. Karrison, Sherin J. Rouhani, Jeremy P. Segal, Ardaman Shergill, Philip C. Hoffman, Jyoti D. Patel, Marina C. Garassino, Everett E. Vokes, Christine M. Bestvina
Publikováno v:
Clinical Lung Cancer. 24:e117-e121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16641b0206eeb48ca714ee08220bc5fe
https://doi.org/10.1016/j.cllc.2023.01.003
https://doi.org/10.1016/j.cllc.2023.01.003
Autor:
Patrick M Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M Awad, Enriqueta Felip, Stephen R Broderick, Julie R Brahmer, Scott J Swanson, Keith Kerr, Changli Wang, Tudor–Eliade Ciuleanu, Gene B Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke Neng Chen, Moishe Liberman, Everett E Vokes, Janis M Taube, Cecile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, Christophe Y Calvet, Nicolas Girard
Publikováno v:
Future Oncology. 19:549-557
What is this summary about? In this article, we summarize results from the ongoing phase 3 CheckMate 816 clinical study that were published in The New England Journal of Medicine in 2022. The goal of CheckMate 816 was to find out if nivolumab, an imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dae900a445d2aaedbeebb7457a197cef
https://doi.org/10.2217/fon-2023-0007
https://doi.org/10.2217/fon-2023-0007